The Clinical Impact of Proton Pump Inhibitors When Co-Administered With Dual Antiplatelet Therapy in Patients Having Acute Myocardial Infarction With Low Risk of Gastrointestinal Bleeding: Insights From the China Acute Myocardial Infarction Registry

Background: The latest guidelines recommend the use of proton pump inhibitors (PPIs) to minimize gastrointestinal bleeding (GIB) in patients receiving dual antiplatelet therapy (DAPT), even though this co-administration may increase the risk of ischemia due to drug interactions. We have noticed that...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wence, Ni, Lin, Yang, Jingang, Fan, Xiaoxue, Yu, Mei, Yang, Hongmei, Yu, Mengyue, Yang, Yuejin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492977/
https://www.ncbi.nlm.nih.gov/pubmed/34631809
http://dx.doi.org/10.3389/fcvm.2021.685072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492977/
https://www.ncbi.nlm.nih.gov/pubmed/34631809
http://dx.doi.org/10.3389/fcvm.2021.685072

Ejemplares similares